Westlake Chemical Partners' Q3'24 results showed increased earnings due to higher ethylene prices and production volumes.

Oppenheimer laid out five “aspirational” potential takeover targets in biotech heading into the annual JPMorgan Health Care Conference. “We ...

Oppenheimer lowered the firm’s price target on U.S. Bancorp to $62 from $66 and keeps an Outperform rating on the shares. For banks, the trend ...

Newport City Council is gearing up for its Regular Council Meeting on Jan. 22 at 6:30 p.m. in the City Hall Council Chambers.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.